The U.S. Drug Enforcement Agency has released its notice of proposed rulemaking for a framework to permit medically necessary controlled substances without an in-person visit without violating the ...
New license expands BioTechnique’s capabilities in controlled‑substance manufacturing and secure pharmaceutical development. YORK, PA, UNITED STATES, March 17 ...
The Drug Enforcement Administration released a notice of proposed rulemaking that would create a three-tiered special registration system for the remote prescribing of controlled substances. An ...
YORK, PA, UNITED STATES, March 17, 2026 / EINPresswire.com / — BioTechnique is pleased to announce the successful issuance of its Drug Enforcement Administration (DEA) manufacturing and handling ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results